DrugPatentWatch Database Preview
Drugs in Development Information for Isoquinoline
» See Plans and Pricing
What is the development status for investigational drug Isoquinoline?
Isoquinoline is an investigational drug.
There have been 11 clinical trials for Isoquinoline.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2018.
The most common disease conditions in clinical trials are Taeniasis, Neurocysticercosis, and Cysticercosis. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), University of Washington, and Kenya Medical Research Institute.
There are three US patents protecting this investigational drug and forty-two international patents.
Summary for Isoquinoline
| US Patents | 3,153 |
| International Patents | 42,638 |
| US Patent Applications | 4,125 |
| WIPO Patent Applications | 2,386 |
| Japanese Patent Applications | 13 |
| Clinical Trial Progress | Phase 1 (2018-07-01) |
| Vendors | 89 |
Recent Clinical Trials for Isoquinoline
| Title | Sponsor | Phase |
|---|---|---|
| Comparation of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients | Tianjin Anding Hospital | Phase 4 |
| Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach | National Center for Complementary and Integrative Health (NCCIH) | Early Phase 1 |
| Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach | Washington State University | Early Phase 1 |
Clinical Trial Summary for Isoquinoline
Top disease conditions for Isoquinoline
Top clinical trial sponsors for Isoquinoline
US Patents for Isoquinoline
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Isoquinoline | Start Trial | Materials for organic electroluminescent devices | Merck Patent GmbH (DE) | Start Trial |
| Isoquinoline | Start Trial | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (Ewing, NJ) | Start Trial |
| Isoquinoline | Start Trial | Compositions and methods for treating Dengue virus infection | The J. David Gladstone Institutes (San Francisco, CA) The Regents of the University of California (Oakland, CA) | Start Trial |
| Isoquinoline | Start Trial | Quinazolinone and isoquinolinone derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (Tokyo, JP) | Start Trial |
| Isoquinoline | Start Trial | Protein kinase C inhibitors and uses thereof | Rigel Pharmaceuticals, Inc. (South San Francisco, CA) | Start Trial |
| Isoquinoline | Start Trial | Highly conductive polymer film compositions from nanoparticle induced phase segregation of counterion templates from conducting polymers | THE UNIVERSITY OF CONNECTICUT (Farmington, CT) | Start Trial |
| Isoquinoline | Start Trial | Materials for organic light emitting diode | UNIVERSAL DISPLAY CORPORATION (Ewing, NJ) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Isoquinoline
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Isoquinoline | China | 105916963 | 2034-01-17 | Start Trial |
| Isoquinoline | European Patent Office | 3094703 | 2034-01-17 | Start Trial |
| Isoquinoline | Japan | 2017508728 | 2034-01-17 | Start Trial |
| Isoquinoline | South Korea | 20160103144 | 2034-01-17 | Start Trial |
| Isoquinoline | World Intellectual Property Organization (WIPO) | 2015106789 | 2034-01-17 | Start Trial |
| Isoquinoline | China | 104844658 | 2034-02-18 | Start Trial |
| Isoquinoline | European Patent Office | 2907820 | 2034-02-18 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
